Online Exclusives

Biologics, Proteins, Vaccines

India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines

CMOs expand and ‘repurpose’ capacities.

S Harachand, Contributing Editor 10.20.20

Clinical Trials | Drug Development | Preclinical Outsourcing

Accelerating R&D Trends

The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.

Kristin Brooks, Contract Pharma 10.20.20

Drug Delivery

Topical Drugs Poised for Growth

The topical drug delivery market is projected to reach $129.8 billion by 2025 from $95.2 billion in 2020, at a CAGR of 6.4%.

Contract Pharma Staff 10.12.20

Drug Delivery

Drug Delivery Market Report

The pharmaceutical drug delivery market was valued at $1,403,082.9 million in 2019 and is projected to reach $2,296,170.9 million by 2027.

Contract Pharma Staff 10.12.20

Parenterals

Primary Packaging Considerations Amid COVID-19 Vax Urgency

Fran L. DeGrazio of West discusses why and how vaccine development is different than drug development and the impacts of COVID-19 on vaccine development.

Kristin Brooks, Contract Pharma 10.05.20

Cold Chain Management | Logistics | Supply Chain

Pharma Supply Chain Logistics & Potential COVID-19 Vaccines

Wes Wheeler of UPS Healthcare explores various complexities, how to minimize supply chain gaps and challenges across the nation and globally.

Kristin Brooks, Contract Pharma 09.17.20

cGMP Manufacture

Keeping Up with Continuous Biopharmaceutical Processing

Keith Fritsky discusses uptake among biomanufacturers and W. L. Gore’s perspective on operation of equipment in continuous processing.

Kristin Brooks, Contract Pharma 09.11.20

COVID-19: Racing for a Vaccine

Amélie Boulais of Sartorius discusses the landscape and challenges for developing a vaccine against the SARS-Cov-2 virus

Kristin Brooks, Contract Pharma 09.09.20

Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs

Expediting a COVID-19 Vaccine: FDA Approval Process

The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.

Kristin Brooks, Contract Pharma 08.25.20

Drug Development | Information Technology

Trade Secret Litigation: Vulnerabilities Within Pharma Amid Hacking Efforts

Theft of IP belonging to companies developing biologics and other drugs, including COVID-19 treatments and vaccines, poses a threat to innovation.

Kristin Brooks, Contract Pharma 08.19.20

Logistics | Supply Chain

Is Blockchain Key to COVID-19 Vaccine Distribution?

The global supply chain has taken a huge hit over the last several months, what role might blockchain play when it comes to vaccine distribution.

Kristin Brooks, Contract Pharma 08.05.20

Vials

Glass Primary Packaging in Today's Pharma Market

Overcoming operational challenges for high-value products leveraging Artificial Intelligence to achieve high inspection performance.

Kristin Brooks, Contract Pharma 07.31.20

Drug Delivery | Solid Dosage/Creams/Ointments

MedPharm Expands U.S. Footprint

UK topical and transdermal firm invests in $4 million expansion of laboratory facility in Durham, NC.

Tim Wright, Editor, Contract Pharma 07.23.20

Drug Development | Industry News

Top Companies Report: Biogen

Expands pipeline of disease-modifying therapies for Alzheimer’s and Parkinson’s, adds gene therapies focused on AAV treatments, bolsters biosimilars portfolio.

Kristin Brooks, Contract Pharma 07.10.20

APIs | Aseptic Processing